5-Fluoro-4-methoxy-2-nitroaniline, 95.0%, 10g

5-(1,5-dimethyl-1H-pyrrol-2-yl)-1H-1,2,3,4-tetrazole, 95+%, 1g

1,3-Oxathiolane-2-carboxylic acid, 5-(4-amino-5-fluoro-2-oxo-1(2H)-pyrimidinyl)-, (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl ester, (2S,5R)-, 5g

2-(4-chloro-1H-pyrazol-1-yl)ethanamine, 1g

(2S,4R)-1-((Benzyloxy)carbonyl)-4-((tert-butoxycarbonyl)amino)pyrrolidine-2-carboxylic acid, 98%, 500mg

2,6-Dichloro-4-(difluoromethyl)nicotinonitrile, 97%, 100mg

1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid methyl ester, 95.0%, 10g

tert-Butyl 2-(trifluoromethyl)acrylate, 97%, 10g

Oxyde de platine(IV) hydraté 1 g

Vinyl terminated polydimethylsiloxane cSt1000, 100g

4,6-Dichlorothieno[2,3-b]pyridine, 97%, 10g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(methylsulfonyl)butanoic acid, 96%, 5g

Theobromine, 98+%, 25g